Literature DB >> 19725025

Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting.

Susan Cleary1, Gavin Mooney, Di McIntyre.   

Abstract

The HIV-epidemic is one of the greatest public health crises to face South Africa. A health care response to the treatment needs of HIV-positive people is a prime example of the desirability of an economic, rational approach to resource allocation in the face of scarcity. Despite this, almost no input based on economic analysis is currently used in national strategic planning. While cost-utility analysis is theoretically able to establish technical efficiency, in practice this is accomplished by comparing an intervention's ICER to a threshold level representing society's maximum willingness to pay to avoid death and improve health-related quality of life. Such an approach has been criticised for a number of reasons, including that it is inconsistent with a fixed budget for health care and that equity is not taken into account. It is also impractical if no national policy on the threshold exists. As an alternative, this paper proposes a mathematical programming approach that is capable of highlighting technical efficiency, equity, the equity/efficiency trade-off and the affordability of alternative HIV-treatment interventions. Government could use this information to plan an HIV-treatment strategy that best meets equity and efficiency objectives within budget constraints.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19725025     DOI: 10.1002/hec.1542

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  20 in total

Review 1.  Setting priorities to address cardiovascular diseases through universal health coverage in low- and middle-income countries.

Authors:  David A Watkins; Rachel A Nugent
Journal:  Heart Asia       Date:  2017-02-21

Review 2.  The state of health economic research in South Africa: a systematic review.

Authors:  Paul Gavaza; Karen L Rascati; Abiola O Oladapo; Star Khoza
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

3.  Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.

Authors:  Thomas Ward; Ruben E Mujica-Mota; Anne E Spencer; Antonieta Medina-Lara
Journal:  Pharmacoeconomics       Date:  2021-10-29       Impact factor: 4.981

4.  Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings.

Authors:  Rory Leisegang; Gary Maartens; Michael Hislop; Leon Regensberg; Susan Cleary
Journal:  BMC Health Serv Res       Date:  2010-07-02       Impact factor: 2.655

5.  Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.

Authors:  Sarah E Rutstein; Joan T Price; Nora E Rosenberg; Stuart M Rennie; Andrea K Biddle; William C Miller
Journal:  Glob Public Health       Date:  2016-05-04

6.  Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?

Authors:  Calvin Chiu; Leigh F Johnson; Lise Jamieson; Bruce A Larson; Gesine Meyer-Rath
Journal:  BMC Public Health       Date:  2017-01-31       Impact factor: 3.295

7.  Health system costs of rheumatic heart disease care in South Africa.

Authors:  Assegid G Hellebo; Liesl J Zuhlke; David A Watkins; Olufunke Alaba
Journal:  BMC Public Health       Date:  2021-07-03       Impact factor: 3.295

8.  Efficient and equitable HIV prevention: A case study of male circumcision in South Africa.

Authors:  Stéphane Verguet
Journal:  Cost Eff Resour Alloc       Date:  2013-01-04

9.  The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.

Authors:  Gesine Meyer-Rath; Jan Pienaar; Brian Brink; Andrew van Zyl; Debbie Muirhead; Alison Grant; Gavin Churchyard; Charlotte Watts; Peter Vickerman
Journal:  PLoS Med       Date:  2015-09-01       Impact factor: 11.069

10.  Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance.

Authors:  Rob Baltussen; Evelinn Mikkelsen; Noor Tromp; Annekarin Hurtig; Jens Byskov; Oystein Olsen; Kristine Bærøe; Jan A Hontelez; Jerome Singh; Ole F Norheim
Journal:  Cost Eff Resour Alloc       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.